Spectral Medical secures $10M for clinical trial looking to improve sepsis diagnostics
Sepsis is a difficult condition to accurately diagnose once symptoms appear. For this reason, Spectral Medical is taking recent funding to further development of its devices designed to detect endotoxin in the bloodstream.